Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials (2023)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(23)00191-x
PubMed Identifier: 37832571
Publication URI: http://europepmc.org/abstract/MED/37832571
Type: Journal Article/Review
Parent Publication: The Lancet Microbe
Issue: 11
ISSN: 2666-5247